4Vote!
TinyTechIP (Free subscription) | 11/26/2009
http://www.freepatentsonline.com/7622129.html In order to treat more extreme cases of bladder cancer it can become necessary to remove a portion of the bladder wall and replace it with a medical implant. This patent from the Purdue Research Foundation teaches such an implant formed via a molding process which produces a nanostructured surface roughness capable of mimicing soft tissue. Claim 1 reads:...
3Vote!
Medical News Today (Free subscription) | 11/25/2009
MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced the extension and expansion of its collaboration with the Vancouver Prostate Centre (VPC), covering the discovery and development of RNAi-based therapeutics for the treatment of bladder cancer.
5Vote!
Market Wire (Free subscription) | 11/24/2009
BOTHELL, WA (MARKET WIRE) MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced the extension and expansion of its collaboration with the Vancouver Prostate Centre (VPC), covering the discovery and development of RNAi-based therapeutics for the treatment of bladder cancer. Research conducted by scientists and surgeons from both institutions demonstrated...
8Vote!
Blazers Edge (Free subscription) | 11/24/2009
Quick: Maurice Lucas's Cancer Has Returned Jason Quick writes ... -------------------- Maurice Lucas, a Trail Blazers legend and current assistant coach, has been in a local hospital for weeks after learning that cancer has returned to his body less than seven months after he underwent surgery to remove bladder cancer. -------------------- -- Ben Golliver | (benjamin.golliver@gmail.com) | Twitter
4Vote!
Business Wire (Free subscription) | 11/23/2009
IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial stage biotechnology company with a primary focus in oncology, and Handok Pharmaceuticals Co., Ltd., a fully integrated Korean pharmaceutical company, today announced a collaboration for the development and commercialization of apaziquone in South Korea. Apaziquone is an antineoplastic agent currently being...
4Vote!
Japan Times (Free subscription) | 11/21/2009
Two years ago journalist and critic Takashi Tachibana was operated on for bladder cancer. The experience made him curious about research into cures for the disease, and what he learned is outlined in "Tachibana Takashi Saizensen Hokoku, Gan to Ningen, Hateshinaku Tatakai" (Takashi Tachibana's Front Line Report, Cancer and Humans, Endless Struggle; NHK-G, Mon., 10 p.m.). Tachibana travels...
4Vote!
Stand Up To Cancer (Free subscription) | 11/20/2009
In the wake of this week's news that the US Preventative Services Task Force has revised its recommendations on screening mammography - more on that in a different entry to come - a new report indicates that only 25% of adults aged 50 to 64 in the US are getting their recommended cancer screenings. "This is really looking at untapped opportunities to improve the health of adults," said the...
11Vote!
Gizmodo (Free subscription) | 11/12/2009
At TEDMED , I witnessed video clips showing science I never knew was so advanced. Dr. Anthony Atala has been growing human tissue and organs, in a lab, for nearly two decades. He's even printed kidneys from a cell-stuffed inkjet printer. The footage below is from the Wake Forest Institute for Regenerative Medicine , one of the world's largest labs dedicated to regenerative medicine —a field...
3Vote!
thepharmaletter.com (Free subscription) | 11/11/2009
The USA’s Spectrum Pharmaceuticals and Japan’s Nippon Kayaku have signed an exclusive collaboration for the development and commercialization of apaziquone in Asia. Apaziquone is an antineoplastic agent currently being investigated for the treatment of non-muscle invasive bladder cancer by intravesical instillation.
4Vote!
Business Wire (Free subscription) | 11/10/2009
IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial stage biotechnology company with a primary focus in oncology, and Nippon Kayaku today announced an exclusive collaboration for the development and commercialization of apaziquone in Asia. Apaziquone is an antineoplastic agent currently being investigated for the treatment of non-muscle invasive bladder cancer...
4Vote!
Radon Mitigation Pittsburgh (Free subscription) | 11/08/2009
Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors Mens Health Network (MHN) urges military veterans to learn about their health risks, especially those linked to exposure to chemicals, atomic agents and soot or smoke from military service. Bladder cancer is one of those cancers that is two times more prevalent in veterans, especially those who...
3Vote!
Nature Publishing Group (Free subscription) | 11/05/2009
A bladder preserving protocol comprising combined external-beam radiotherapy and interstitial brachytherapy for the treatment of bladder cancer has been reported as a viable alternative to cystectomy. However, we have concerns regarding the oncological efficacy of this approach and believe important quality of life issues need to be addressed.
4Vote!
PR News Wire (Free subscription) | 11/03/2009
NEW YORK, Nov. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
4Vote!
Business Wire (Free subscription) | 11/03/2009
LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences Inc. today announced the publication of pilot study results in the November issue of the Journal of Urology, highlighting the Company’s novel urinary biomarker approach to bladder cancer detection that achieves exceptionally high Negative and Positive Predictive Values (NPV and PPV). The study demonstrates that Predictive’s unique...
3Vote!
Medical News Today (Free subscription) | 11/02/2009
BSD Medical Corporation (NASDAQ:BSDM) announced that published study results demonstrated improvement in overall survival, tumor response rates, and local tumor control from the addition of hyperthermia therapy, delivered using the BSD-2000 Hyperthermia System, to the standard treatment regimen for 45 patients with high-risk bladder cancer.
3Vote!
aarkstore | 10/28/2009
Bladder Cancer Therapy Area Pipeline Report contains detailed information on the bladder cancer drug pipeline. This report provides insight into the pipeline status of bladder cancer drugs by company and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on...
5Vote!
aasthahealthcare | 09/09/2009
Urology is a surgical specialty which deals with diseases of the male and female urinary tract and the male reproductive organs. The complexity of knowledge and rapid development of technologies used to assess and treat the conditions affecting the genito-urinary tract have prompted the development of subspecialties within urology. Endourology involves the use of small fibre optic scopes which can...
6Vote!
aasthahealthcare | 09/09/2009
What is bladder? A bladder is a muscular hollow organ that stores urine. It is located in the pelvic region. Urine from both the kidneys passes through ureter and reaches the bladder. When the bladder gets filled up to a certain level, the nerves send signal to the brain and we may feel the urge to urinate. What is Bladder cancer? Normally, cells grow and divide to form new cells as the body needs...
Videos